Laidlaw Wealth Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-3,369
| Closed | -$273K | – | 196 |
|
|
2023
Q4 | $273K | Buy |
3,369
+95
| +3% | +$7.7K | 0.1% | 193 |
|
|
2023
Q3 | $245K | Buy |
3,274
+115
| +4% | +$8.62K | 0.08% | 226 |
|
|
2023
Q2 | $243K | Sell |
3,159
-788
| -20% | -$60.7K | 0.05% | 297 |
|
|
2023
Q1 | $328K | Sell |
3,947
-176
| -4% | -$14.6K | 0.07% | 247 |
|
|
2022
Q4 | $354K | Sell |
4,123
-334
| -7% | -$28.7K | 0.08% | 241 |
|
|
2022
Q3 | $275K | Sell |
4,457
-456
| -9% | -$28.1K | 0.06% | 253 |
|
|
2022
Q2 | $304K | Buy |
4,913
+43
| +0.9% | +$2.66K | 0.06% | 263 |
|
|
2022
Q1 | $290K | Buy |
4,870
+131
| +3% | +$7.8K | 0.05% | 306 |
|
|
2021
Q4 | $344K | Buy |
+4,739
| New | +$344K | 0.06% | 280 |
|
|
2021
Q1 | – | Sell |
-3,693
| Closed | -$215K | – | 272 |
|
|
2020
Q4 | $215K | Buy |
+3,693
| New | +$215K | 0.05% | 325 |
|
|
2020
Q2 | – | Sell |
-3,490
| Closed | -$261K | – | 186 |
|
|
2020
Q1 | $261K | Buy |
+3,490
| New | +$261K | 0.17% | 121 |
|